✦ LIBER ✦

Asymptomatic shedding of herpes simplex virus into the oral cavity of patients with atopic dermatitis

✍ Scribed by M Yoshida; A Amatsu

Book ID: 117771629
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 90 KB
Volume: 16
Category: Article
ISSN: 1386-6532
DOI: 10.1016/s1386-6532(99)00057-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Asymptomatic shedding of herpes simplex

Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity

✍ Craig S. Miller; Robert J. Danaher 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Herpes simplex virus type 1 shedding in

Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients

✍ LM Da Silva; ALS Guimarães; JMN Victória; CC Gomes; RS Gomez 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Shedding of herpes simplex virus type 1

Shedding of herpes simplex virus type 1 into saliva in patients with orofacial fracture

✍ Dr. T. Kameyama; M. Futami; N. Nakayoshi; C. Sujaku; S. Yamamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Shedding of herpes simplex virus type 1 (HSV-1) into saliva was studied in 83 patients with orofacial fractures. Infectious virus was isolated from 14 of 83 patients (16.8%) with no detectable herpetic lesion during hospitalization. Of the 83 patients, 44 (53%) had HSV-1 specific antibody. Virus she

The prevalence of herpes simplex virus s

The prevalence of herpes simplex virus shedding and infection in the oral cavity of seropositive patients undergoing head and neck radiation therapy

✍ Joel B. Epstein; Meir Gorsky; Pamela Hancock; Nancy Peters; C.H. Sherlock 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Comparable risk of herpes simplex virus

Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis

✍ H. Hashizume; H. Yagi; A. Ohshima; T. Ito; N. Horibe; Y. Yoshinari; M. Takigawa; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Potential for efficacy of the oncolytic

Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma

✍ Alastair T. M. Mace; Ian Ganly; David S. Soutar; S. Moira Brown 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 1 views

## Abstract ## Background. Herpes simplex virus (HSV) 1716 is a selectively replicating oncolytic virus. Our objective was to assess the potential efficacy of HSV1716 in patients with oral squamous cell carcinoma (SCC) by intratumoral injection. ## Methods. Twenty patients with oral SCC had a si